The relationship between cognitive impairment plasma cortisol levels and HPA responsibility to dexamethasone in dementia. 1989

D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
Wayne State University, School of Medicine, Department of Psychiatry.

Previous studies show an association between increased plasma cortisol levels and aging, a process which is also associated with some deterioration of cognition. Animal studies demonstrated damage to pyramidal cells in the hippocampus, secondary to increased cortisol secretion. Conditions in which high cortisol plasma levels are encountered suggest an association between elevated cortisol levels and cognitive impairment. 34 patients drug free for at least 10 days, were challenged by 0.5mg dexamethasone. Pre- and post-challenge cortisol plasma levels were determined by RIA. Cognitive functioning was assessed by the GDS (34 subjects) and later also by the MMSE (17 subjects). Mean GDS score was 5.2 +/- 1.1 (Mean +/- SD) and mean MMSE score was 11.3 +/- 5.8. Mean preDEX and postDEX cortisol plasma levels were 17.03 +/- 6.67 micrograms/dl and 9.95 +/- 6.70 micrograms/dl respectively. Grouping patients by severity of dysfunction, we found that the more severely impaired patients had significantly higher postDEX cortisol levels 7.04 +/- 6.25 vs 12.87 +/- 5.96 (t = -2.7 P less than 0.009 for the GDS scale and 5.74 +/- 6.1 vs 13.82 +/- 6.32, (t = 02.63 P less than 0.019 for the MMSE scale) but no significant difference for preDEX cortisol levels. The Index of HPA Responsivity, defined as: (PreDEX Cortisol-PostDEX Cortisol)/Pre DEX Cortisol+PostDEX Cortisol), was significantly lower for the more impaired patients indicating a less responsive HPA axis in those patients. Pearson correlation between the Index vs the GDS and MMSE scores was -0.43 (F = 7.11, P less than 0.012, n = 34) and 0.49 (F = 4.89, P less than 0.043, n = 17) respectively. Age did not seem to play an important role in this sample. These findings support a relationship between plasma cortisol levels and cognitive impairment. The Index of Responsivity, a dynamic measure of the system, is suggested for future studies.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
January 1990, Progress in neuro-psychopharmacology & biological psychiatry,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
November 2002, Brain and cognition,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
January 1994, Dementia (Basel, Switzerland),
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
June 2011, Journal of the neurological sciences,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
August 2013, Clinica chimica acta; international journal of clinical chemistry,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
January 1989, Biological psychiatry,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
July 1973, The Journal of endocrinology,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
December 1984, The American journal of psychiatry,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
January 2002, Journal of psychiatric research,
D Gurevitch, and B Siegel, and M S Dumlao, and E Perl, and P Chaitin, and C A Bagne, and G F Oxenkrug
January 1989, Journal of affective disorders,
Copied contents to your clipboard!